이가희 교수

The incidence of thyroid cancer has rapidly increased, with a decrease in tumors of large size, LN involvement, and ETE, although the decreasing rates of LN involvement and ETE were not as prominent as decreasing rates of large size tumors. The mortality and recurrence rates have also decreased. Future long-term follow-up of patients diagnosed in the most recent decade is needed to confirm the prognostic characteristics of Korean PTC patients.

The coexistence of BRAF or RAS mutations enhanced the prognostic effects of TERT promoter mutations. Furthermore, TERT promoter mutations strengthened the predictions of mortality and recurrence by the ATA and TNM staging systems, particularly for high-risk patients with DTC. Cancer 2016;122:1370-1379. © 2016 American Cancer Society.

The high prevalence of thyroid nodules in people who underwent thyroid US at a health checkup suggests that increased detection of thyroid nodules resulted in an increased prevalence in the general population. However, metabolic disturbances may also have contributed to the increase in thyroid nodule prevalence in Korea.

Increased detection of thyroid nodules using high-resolution ultrasonography has resulted in a world-wide increase in the incidence of differentiated thyroid cancer (DTC). Despite the steep increase in its incidence, the age-standardized mortality rate of thyroid cancer has remained stable, which leads toward a trend of more conservative treatment. The latest American Thyroid Association (ATA) guidelines for thyroid nodules and thyroid cancer revised in 2015 suggested that fine needle aspiration

Our results validated 1.0 ng/mL of FNA-Tg as a cutoff value for diagnosing LN metastasis of PTC and suggested that serum TSH suppression and serum Tg presence should be considered in diagnosing LN malignancy with FNA-Tg in PTC patients.

The prognosis of lung metastasis from DTC in Korea within this study was favorable. (131)I nonavidity, observed more frequently in late metastasis, was the only independent factor predicting poor prognosis.

, (5-10%) . 10 , .

, (5~10%) . 10 , . ,

. . (82.7%), (13.3%), (3.5%), (0.5%) . 1) (thyroid stimulating hormone, TSH) , .

A second course of ATD can be considered for GD patients after the first relapse because the chance of remission and the relapse rate are similar to the one after the first ATD treatment course. For GD patients with more than two relapses, or with an ATD treatment duration of more than four to five years, low-dose maintenance of ATD or ablative treatment needs to be considered.

Thyroid cancer is the most common malignancy in Korea; in 2012, about 44,000 new cases (19.6% of all malignancies) were registered and the estimated age-standardized incidence rate of thyroid cancer was 73.6 per 100,000 (17.3 and 88.6 per 100,000 in men and women, respectively). Despite the steep increase in its incidence, the age-standardized mortality rate of thyroid cancer has remained stable and 10-year relative survival rate is 99.2%. Increased detection using high-resolution ultrasonograph

. 10% 20-30% . T4 T3 50% 50% .

The aim of this study was to evaluate preoperatively identifiable clinical and ultrasonographic characteristics associated with central lymph node metastasis (CLNM) in clinically node negative papillary thyroid carcinoma (PTC) patients. Records of the patients who underwent thyroidectomy with prophylactic central lymph node dissection due to clinically node negative PTC (size, 1.0-3.0 cm) were reviewed. Of a total of 174 patients, 71 (40.8%) had CLNMs. CLNM was more associated with capsule invas

갑상선결절은 매우 흔하며, 그 임상적 중요성은 결절의 일 부(5~10%)가 갑상선암이라는 사실에 근거한다. 최근 10여 년간 갑상선결절 및 갑상선 분화암의 진단과 치료 분야에서 많은 발전이 있었으며, 갑상선결절 또는 갑상선암의 치료 권 고 안들이 여러 차례 발표된 바 있었다. 그러나 발표된 치료 권고안들 간에도 상충되는 내용이 있고, 아직 임상적으로나 보건의료학적 관점에서 논란이 되는 사항들이 많은 실정이 다. 대한내분비학회 갑상선분과회에서는 갑상선결절 및 갑 상선암 환자의 진료에 종사하는 여러 분야의 의사들에게 도 움을 주고자 2007년 “갑 상선결절 및 암 진료권고안”을 제 정하였다. 이 진료 권고안은 국내 주요 의료기관들에서 갑 상선질환 환자를 진료하고 있는 대한내분비학회 회원인 내 Special Contribution Korean J Otorhinolaryngol-Head Neck Surg 2011;54:8-36 / DOI 10.3342/kjorl-hns.2011.54.1.8